SQUAWK/NEWS
Account
Theme
Account
Menu
Live News GEOPOLITICS FLASH L impact

ESMO: In sac-TMT’s First Global Phase 3 Win, Merck Sees ‘Pretty Consistent’ Data With China - Fierce Pharma